VibroSense Dynamics AB (VibroSense) has signed an exclusive distributor agreement with the Chinese state-owned company Genertec Universal Medical Group (UMCARE). The distributor agreement means that UMCARE receives the exclusive right to sell VibroSense's product VibroSense Meter® II, targeting screening of diabetic feet, in the Chinese market. The agreement also includes agreements of extensive marketing and sales execution by UMCARE in the Chinese market.

UMCARE will also be responsible for the execution and submission of a regulatory market approval in China, which is defined in a separate agreement signed between the parties in December 2021. Sales with deliveries will start when VibroSense Meter® II has received regulatory market approval in China, which is estimated to be finalized during Second Quarter 2023.